De-risk your inhaled drug development

Unlock your inhaled drug development with data that goes further.

Inhalation Sciences delivers exceptionally detailed insights early in development, empowering you to make confident, informed decisions.

An FDA-funded study shows that DissolvIt^® has the potential to generate data that can be used to predict clinical plasma profiles.

Why work with us?

• Gain rich, clinically relevant data earlier in development

• Reduce uncertainty and improve trial outcomes

• Advance with a proven platform for smarter and faster progress

Explore the PreciseInhale® Technology Platform

• Download White Paper

Ulf Wedenberg

Chief Commercial Officer